Structural characterisation of the insulin-like growth factor (IGF) binding proteins and IGF receptors, their interactions with other physiological molecules and alterations in metabolic disorders

Link to this page

info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173042/RS//

Structural characterisation of the insulin-like growth factor (IGF) binding proteins and IGF receptors, their interactions with other physiological molecules and alterations in metabolic disorders (en)
Структурне карактеристике везујућих протеина и рецептора за инсулину сличне факторе раста (IGF), њихове интеракције са другим физиолошким молекулима и промене код поремећаја метаболизма (sr)
Strukturne karakteristike vezujućih proteina i receptora za insulinu slične faktore rasta (IGF), njihove interakcije sa drugim fiziološkim molekulima i promene kod poremećaja metabolizma (sr_RS)
Authors

Publications

Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation

Gligorijević, Nikola; Vasović, Tamara; Lević, Steva M.; Miljević, Čedo; Nedić, Olgica; Nikolić, Milan

(Elsevier, 2020)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Vasović, Tamara
AU  - Lević, Steva M.
AU  - Miljević, Čedo
AU  - Nedić, Olgica
AU  - Nikolić, Milan
PY  - 2020
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3886
AB  - Clozapine is an atypical antipsychotic used for the treatment of schizophrenia. The prescribed target daily doses may reach 900 mg. Literature studies report a connection between clozapine usage and thrombosis development. Our in vitro study aimed to provide insight into molecular bases of this observation, investigating clozapine binding to fibrinogen, the main plasma protein involved in hemostasis. Fibrinogen/clozapine interaction was confirmed by protein fluorescence quenching, with an affinity constant of 1.7 × 105 M−1. Direct interactions did not affect the structure of fibrinogen, nor fibrinogen melting temperature. Clozapine binding affected fibrin formation by reducing coagulation speed and thickness of fibrin fibers suggesting that in the presence of clozapine, fibrinogen may acquire thrombogenic characteristics. Although no difference in fibrin gel porosity was detected, other factors present in the blood may act synergistically with altered fibrin formation to modify fibrin clot, thus increasing the risk for development of thrombosis in patients on clozapine treatment. ORAC and HORAC assays showed that clozapine reduced free radical-induced oxidation of fibrinogen. All observed effects of clozapine on fibrinogen are dose-dependent, with the effect on fibrin formation being more pronounced.
PB  - Elsevier
T2  - International Journal of Biological Macromolecules
T1  - Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation
VL  - 154
SP  - 142
EP  - 149
DO  - 10.1016/j.ijbiomac.2020.03.119
ER  - 
@article{
author = "Gligorijević, Nikola and Vasović, Tamara and Lević, Steva M. and Miljević, Čedo and Nedić, Olgica and Nikolić, Milan",
year = "2020",
abstract = "Clozapine is an atypical antipsychotic used for the treatment of schizophrenia. The prescribed target daily doses may reach 900 mg. Literature studies report a connection between clozapine usage and thrombosis development. Our in vitro study aimed to provide insight into molecular bases of this observation, investigating clozapine binding to fibrinogen, the main plasma protein involved in hemostasis. Fibrinogen/clozapine interaction was confirmed by protein fluorescence quenching, with an affinity constant of 1.7 × 105 M−1. Direct interactions did not affect the structure of fibrinogen, nor fibrinogen melting temperature. Clozapine binding affected fibrin formation by reducing coagulation speed and thickness of fibrin fibers suggesting that in the presence of clozapine, fibrinogen may acquire thrombogenic characteristics. Although no difference in fibrin gel porosity was detected, other factors present in the blood may act synergistically with altered fibrin formation to modify fibrin clot, thus increasing the risk for development of thrombosis in patients on clozapine treatment. ORAC and HORAC assays showed that clozapine reduced free radical-induced oxidation of fibrinogen. All observed effects of clozapine on fibrinogen are dose-dependent, with the effect on fibrin formation being more pronounced.",
publisher = "Elsevier",
journal = "International Journal of Biological Macromolecules",
title = "Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation",
volume = "154",
pages = "142-149",
doi = "10.1016/j.ijbiomac.2020.03.119"
}
Gligorijević, N., Vasović, T., Lević, S. M., Miljević, Č., Nedić, O.,& Nikolić, M.. (2020). Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation. in International Journal of Biological Macromolecules
Elsevier., 154, 142-149.
https://doi.org/10.1016/j.ijbiomac.2020.03.119
Gligorijević N, Vasović T, Lević SM, Miljević Č, Nedić O, Nikolić M. Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation. in International Journal of Biological Macromolecules. 2020;154:142-149.
doi:10.1016/j.ijbiomac.2020.03.119 .
Gligorijević, Nikola, Vasović, Tamara, Lević, Steva M., Miljević, Čedo, Nedić, Olgica, Nikolić, Milan, "Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation" in International Journal of Biological Macromolecules, 154 (2020):142-149,
https://doi.org/10.1016/j.ijbiomac.2020.03.119 . .
11
2
10
9

Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation

Gligorijević, Nikola; Vasović, Tamara; Lević, Steva M.; Miljević, Čedo; Nedić, Olgica; Nikolić, Milan

(Elsevier, 2020)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Vasović, Tamara
AU  - Lević, Steva M.
AU  - Miljević, Čedo
AU  - Nedić, Olgica
AU  - Nikolić, Milan
PY  - 2020
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3896
AB  - Clozapine is an atypical antipsychotic used for the treatment of schizophrenia. The prescribed target daily doses may reach 900 mg. Literature studies report a connection between clozapine usage and thrombosis development. Our in vitro study aimed to provide insight into molecular bases of this observation, investigating clozapine binding to fibrinogen, the main plasma protein involved in hemostasis. Fibrinogen/clozapine interaction was confirmed by protein fluorescence quenching, with an affinity constant of 1.7 × 105 M−1. Direct interactions did not affect the structure of fibrinogen, nor fibrinogen melting temperature. Clozapine binding affected fibrin formation by reducing coagulation speed and thickness of fibrin fibers suggesting that in the presence of clozapine, fibrinogen may acquire thrombogenic characteristics. Although no difference in fibrin gel porosity was detected, other factors present in the blood may act synergistically with altered fibrin formation to modify fibrin clot, thus increasing the risk for development of thrombosis in patients on clozapine treatment. ORAC and HORAC assays showed that clozapine reduced free radical-induced oxidation of fibrinogen. All observed effects of clozapine on fibrinogen are dose-dependent, with the effect on fibrin formation being more pronounced.
PB  - Elsevier
T2  - International Journal of Biological Macromolecules
T1  - Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation
VL  - 154
SP  - 142
EP  - 149
DO  - 10.1016/j.ijbiomac.2020.03.119
ER  - 
@article{
author = "Gligorijević, Nikola and Vasović, Tamara and Lević, Steva M. and Miljević, Čedo and Nedić, Olgica and Nikolić, Milan",
year = "2020",
abstract = "Clozapine is an atypical antipsychotic used for the treatment of schizophrenia. The prescribed target daily doses may reach 900 mg. Literature studies report a connection between clozapine usage and thrombosis development. Our in vitro study aimed to provide insight into molecular bases of this observation, investigating clozapine binding to fibrinogen, the main plasma protein involved in hemostasis. Fibrinogen/clozapine interaction was confirmed by protein fluorescence quenching, with an affinity constant of 1.7 × 105 M−1. Direct interactions did not affect the structure of fibrinogen, nor fibrinogen melting temperature. Clozapine binding affected fibrin formation by reducing coagulation speed and thickness of fibrin fibers suggesting that in the presence of clozapine, fibrinogen may acquire thrombogenic characteristics. Although no difference in fibrin gel porosity was detected, other factors present in the blood may act synergistically with altered fibrin formation to modify fibrin clot, thus increasing the risk for development of thrombosis in patients on clozapine treatment. ORAC and HORAC assays showed that clozapine reduced free radical-induced oxidation of fibrinogen. All observed effects of clozapine on fibrinogen are dose-dependent, with the effect on fibrin formation being more pronounced.",
publisher = "Elsevier",
journal = "International Journal of Biological Macromolecules",
title = "Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation",
volume = "154",
pages = "142-149",
doi = "10.1016/j.ijbiomac.2020.03.119"
}
Gligorijević, N., Vasović, T., Lević, S. M., Miljević, Č., Nedić, O.,& Nikolić, M.. (2020). Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation. in International Journal of Biological Macromolecules
Elsevier., 154, 142-149.
https://doi.org/10.1016/j.ijbiomac.2020.03.119
Gligorijević N, Vasović T, Lević SM, Miljević Č, Nedić O, Nikolić M. Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation. in International Journal of Biological Macromolecules. 2020;154:142-149.
doi:10.1016/j.ijbiomac.2020.03.119 .
Gligorijević, Nikola, Vasović, Tamara, Lević, Steva M., Miljević, Čedo, Nedić, Olgica, Nikolić, Milan, "Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation" in International Journal of Biological Macromolecules, 154 (2020):142-149,
https://doi.org/10.1016/j.ijbiomac.2020.03.119 . .
11
2
10
9

Characterisation and the effects of bilirubin binding to human fibrinogen

Gligorijević, Nikola; Minić, Simeon L.; Robajac, Dragana B.; Nikolić, Milan; Ćirković-Veličković, Tanja; Nedić, Olgica

(2019)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Minić, Simeon L.
AU  - Robajac, Dragana B.
AU  - Nikolić, Milan
AU  - Ćirković-Veličković, Tanja
AU  - Nedić, Olgica
PY  - 2019
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2824
AB  - Fibrinogen, a protein involved in blood coagulation, is very susceptible to oxidation. Oxidation alters its function and usually makes it more thrombogenic. Bilirubin, an end-product of the haem degradation in vertebrates, is known for its antioxidant properties. The present paper describes interaction between fibrinogen and bilirubin, and the influence of bilirubin on the formation of fibrin and protection against oxidation. The binding constant of 4.5 × 104 M−1 was determined for the fibrinogen/bilirubin complex at 37 °C. There is no change in secondary and tertiary structure of fibrinogen or its thermal stability upon bilirubin binding. The binding site of fibrinogen is not stereospecific for bilirubin and is able to accommodate both bilirubin conformers. A change in absorption maximum of bilirubin occurs upon its interaction with fibrinogen, suggesting an alteration in the conformation of bilirubin to the more cyclic one. Bilirubin exerts antioxidant effect on fibrinogen, preventing its carbonylation and aggregation. The presence of bilirubin induces the formation of fibrin with thicker fibres, as assessed by the coagulation assay. Fibrinogen and bilirubin interact at physiological concentrations, bilirubin may act as an antioxidant for fibrinogen and may modulate an important event in haemostasis, which altogether suggests possible physiological relevance of this interaction.
T2  - International Journal of Biological Macromolecules
T1  - Characterisation and the effects of bilirubin binding to human fibrinogen
VL  - 128
SP  - 74
EP  - 79
DO  - 10.1016/j.ijbiomac.2019.01.124
ER  - 
@article{
author = "Gligorijević, Nikola and Minić, Simeon L. and Robajac, Dragana B. and Nikolić, Milan and Ćirković-Veličković, Tanja and Nedić, Olgica",
year = "2019",
abstract = "Fibrinogen, a protein involved in blood coagulation, is very susceptible to oxidation. Oxidation alters its function and usually makes it more thrombogenic. Bilirubin, an end-product of the haem degradation in vertebrates, is known for its antioxidant properties. The present paper describes interaction between fibrinogen and bilirubin, and the influence of bilirubin on the formation of fibrin and protection against oxidation. The binding constant of 4.5 × 104 M−1 was determined for the fibrinogen/bilirubin complex at 37 °C. There is no change in secondary and tertiary structure of fibrinogen or its thermal stability upon bilirubin binding. The binding site of fibrinogen is not stereospecific for bilirubin and is able to accommodate both bilirubin conformers. A change in absorption maximum of bilirubin occurs upon its interaction with fibrinogen, suggesting an alteration in the conformation of bilirubin to the more cyclic one. Bilirubin exerts antioxidant effect on fibrinogen, preventing its carbonylation and aggregation. The presence of bilirubin induces the formation of fibrin with thicker fibres, as assessed by the coagulation assay. Fibrinogen and bilirubin interact at physiological concentrations, bilirubin may act as an antioxidant for fibrinogen and may modulate an important event in haemostasis, which altogether suggests possible physiological relevance of this interaction.",
journal = "International Journal of Biological Macromolecules",
title = "Characterisation and the effects of bilirubin binding to human fibrinogen",
volume = "128",
pages = "74-79",
doi = "10.1016/j.ijbiomac.2019.01.124"
}
Gligorijević, N., Minić, S. L., Robajac, D. B., Nikolić, M., Ćirković-Veličković, T.,& Nedić, O.. (2019). Characterisation and the effects of bilirubin binding to human fibrinogen. in International Journal of Biological Macromolecules, 128, 74-79.
https://doi.org/10.1016/j.ijbiomac.2019.01.124
Gligorijević N, Minić SL, Robajac DB, Nikolić M, Ćirković-Veličković T, Nedić O. Characterisation and the effects of bilirubin binding to human fibrinogen. in International Journal of Biological Macromolecules. 2019;128:74-79.
doi:10.1016/j.ijbiomac.2019.01.124 .
Gligorijević, Nikola, Minić, Simeon L., Robajac, Dragana B., Nikolić, Milan, Ćirković-Veličković, Tanja, Nedić, Olgica, "Characterisation and the effects of bilirubin binding to human fibrinogen" in International Journal of Biological Macromolecules, 128 (2019):74-79,
https://doi.org/10.1016/j.ijbiomac.2019.01.124 . .
14
6
14
13

Characterisation and the effects of bilirubin binding to human fibrinogen

Gligorijević, Nikola; Minić, Simeon L.; Robajac, Dragana B.; Nikolić, Milan; Ćirković-Veličković, Tanja; Nedić, Olgica

(2019)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Minić, Simeon L.
AU  - Robajac, Dragana B.
AU  - Nikolić, Milan
AU  - Ćirković-Veličković, Tanja
AU  - Nedić, Olgica
PY  - 2019
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2825
AB  - Fibrinogen, a protein involved in blood coagulation, is very susceptible to oxidation. Oxidation alters its function and usually makes it more thrombogenic. Bilirubin, an end-product of the haem degradation in vertebrates, is known for its antioxidant properties. The present paper describes interaction between fibrinogen and bilirubin, and the influence of bilirubin on the formation of fibrin and protection against oxidation. The binding constant of 4.5 × 104 M−1 was determined for the fibrinogen/bilirubin complex at 37 °C. There is no change in secondary and tertiary structure of fibrinogen or its thermal stability upon bilirubin binding. The binding site of fibrinogen is not stereospecific for bilirubin and is able to accommodate both bilirubin conformers. A change in absorption maximum of bilirubin occurs upon its interaction with fibrinogen, suggesting an alteration in the conformation of bilirubin to the more cyclic one. Bilirubin exerts antioxidant effect on fibrinogen, preventing its carbonylation and aggregation. The presence of bilirubin induces the formation of fibrin with thicker fibres, as assessed by the coagulation assay. Fibrinogen and bilirubin interact at physiological concentrations, bilirubin may act as an antioxidant for fibrinogen and may modulate an important event in haemostasis, which altogether suggests possible physiological relevance of this interaction.
T2  - International Journal of Biological Macromolecules
T1  - Characterisation and the effects of bilirubin binding to human fibrinogen
VL  - 128
SP  - 74
EP  - 79
DO  - 10.1016/j.ijbiomac.2019.01.124
ER  - 
@article{
author = "Gligorijević, Nikola and Minić, Simeon L. and Robajac, Dragana B. and Nikolić, Milan and Ćirković-Veličković, Tanja and Nedić, Olgica",
year = "2019",
abstract = "Fibrinogen, a protein involved in blood coagulation, is very susceptible to oxidation. Oxidation alters its function and usually makes it more thrombogenic. Bilirubin, an end-product of the haem degradation in vertebrates, is known for its antioxidant properties. The present paper describes interaction between fibrinogen and bilirubin, and the influence of bilirubin on the formation of fibrin and protection against oxidation. The binding constant of 4.5 × 104 M−1 was determined for the fibrinogen/bilirubin complex at 37 °C. There is no change in secondary and tertiary structure of fibrinogen or its thermal stability upon bilirubin binding. The binding site of fibrinogen is not stereospecific for bilirubin and is able to accommodate both bilirubin conformers. A change in absorption maximum of bilirubin occurs upon its interaction with fibrinogen, suggesting an alteration in the conformation of bilirubin to the more cyclic one. Bilirubin exerts antioxidant effect on fibrinogen, preventing its carbonylation and aggregation. The presence of bilirubin induces the formation of fibrin with thicker fibres, as assessed by the coagulation assay. Fibrinogen and bilirubin interact at physiological concentrations, bilirubin may act as an antioxidant for fibrinogen and may modulate an important event in haemostasis, which altogether suggests possible physiological relevance of this interaction.",
journal = "International Journal of Biological Macromolecules",
title = "Characterisation and the effects of bilirubin binding to human fibrinogen",
volume = "128",
pages = "74-79",
doi = "10.1016/j.ijbiomac.2019.01.124"
}
Gligorijević, N., Minić, S. L., Robajac, D. B., Nikolić, M., Ćirković-Veličković, T.,& Nedić, O.. (2019). Characterisation and the effects of bilirubin binding to human fibrinogen. in International Journal of Biological Macromolecules, 128, 74-79.
https://doi.org/10.1016/j.ijbiomac.2019.01.124
Gligorijević N, Minić SL, Robajac DB, Nikolić M, Ćirković-Veličković T, Nedić O. Characterisation and the effects of bilirubin binding to human fibrinogen. in International Journal of Biological Macromolecules. 2019;128:74-79.
doi:10.1016/j.ijbiomac.2019.01.124 .
Gligorijević, Nikola, Minić, Simeon L., Robajac, Dragana B., Nikolić, Milan, Ćirković-Veličković, Tanja, Nedić, Olgica, "Characterisation and the effects of bilirubin binding to human fibrinogen" in International Journal of Biological Macromolecules, 128 (2019):74-79,
https://doi.org/10.1016/j.ijbiomac.2019.01.124 . .
14
6
14
13

Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124

Gligorijević, Nikola; Minić, Simeon L.; Robajac, Dragana B.; Nikolić, Milan; Ćirković-Veličković, Tanja; Nedić, Olgica

(2019)

TY  - DATA
AU  - Gligorijević, Nikola
AU  - Minić, Simeon L.
AU  - Robajac, Dragana B.
AU  - Nikolić, Milan
AU  - Ćirković-Veličković, Tanja
AU  - Nedić, Olgica
PY  - 2019
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2937
T2  - International Journal of Biological Macromolecules
T1  - Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124
UR  - https://hdl.handle.net/21.15107/rcub_cherry_2937
ER  - 
@misc{
author = "Gligorijević, Nikola and Minić, Simeon L. and Robajac, Dragana B. and Nikolić, Milan and Ćirković-Veličković, Tanja and Nedić, Olgica",
year = "2019",
journal = "International Journal of Biological Macromolecules",
title = "Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124",
url = "https://hdl.handle.net/21.15107/rcub_cherry_2937"
}
Gligorijević, N., Minić, S. L., Robajac, D. B., Nikolić, M., Ćirković-Veličković, T.,& Nedić, O.. (2019). Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124. in International Journal of Biological Macromolecules.
https://hdl.handle.net/21.15107/rcub_cherry_2937
Gligorijević N, Minić SL, Robajac DB, Nikolić M, Ćirković-Veličković T, Nedić O. Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124. in International Journal of Biological Macromolecules. 2019;.
https://hdl.handle.net/21.15107/rcub_cherry_2937 .
Gligorijević, Nikola, Minić, Simeon L., Robajac, Dragana B., Nikolić, Milan, Ćirković-Veličković, Tanja, Nedić, Olgica, "Supplementary data for the article: Gligorijević, N.; Minić, S. L.; Robajac, D. B.; Nikolić, M.; Ćirković-Veličković, T.; Nedić, O. Characterisation and the Effects of Bilirubin Binding to Human Fibrinogen. International Journal of Biological Macromolecules 2019, 128, 74–79. https://doi.org/10.1016/j.ijbiomac.2019.01.124" in International Journal of Biological Macromolecules (2019),
https://hdl.handle.net/21.15107/rcub_cherry_2937 .

Structural changes of fibrinogen as a consequence of cirrhosis

Gligorijević, Nikola; Minić, Simeon L.; Krizakova, Martina; Katrlik, Jaroslav; Nedić, Olgica

(Pergamon-Elsevier Science Ltd, Oxford, 2018)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Minić, Simeon L.
AU  - Krizakova, Martina
AU  - Katrlik, Jaroslav
AU  - Nedić, Olgica
PY  - 2018
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2142
AB  - Cirrhosis is a disease which may develop as a consequence of various conditions. In advanced liver disease, blood coagulation can be seriously affected. Portal hypertension, vascular abnormalities and/or a dysbalance in coagulation factors may result in bleeding disorders or in the development of thrombosis. Fibrinogen is the main protein involved in clot formation and wound healing. The aim of this work was to analyse the glycosylation pattern of the isolated fibrinogen molecules by lectin-based protein microarray, together with the carbonylation pattern of the individual fibrinogen chains, possible changes in the molecular secondary and tertiary structure and reactivity with the insulin-like growth factor-binding protein 1 (IGFBP-1) in patients with cirrhosis. The results pointed to an increase in several carbohydrate moieties: tri/tetra-antennary structures, Gal beta-1,4 GlcNAc, terminal alpha-2,3 Sia and alpha-1,3 Man, and a decrease in core alpha-1,6 Fuc and bi-antennary galactosylated N-glycans with bisecting GlcNAc. Fibrinogen A alpha chain was the most susceptible to carbonylation, followed by the B beta chain. Cirrhosis induced additional protein carbonylation, mostly on the alpha chain. Spectrofluorimetry and CD spectrometry detected reduction in the alpha-helix content, protein unfolding and/or appearance of modified amino acid residues in cirrhosis. The amount of complexes which fibrinogen forms with IGFBP-1, another factor involved in wound healing was significantly greater in patients with cirrhosis than in healthy individuals. A more detailed knowledge of individual molecules in coagulation process may contribute to deeper understanding of coagulopathies and the results of this study offer additional information on the possible mechanisms involved in impaired coagulation due to cirrhosis.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - Structural changes of fibrinogen as a consequence of cirrhosis
VL  - 166
SP  - 43
EP  - 49
DO  - 10.1016/j.thromres.2018.04.005
ER  - 
@article{
author = "Gligorijević, Nikola and Minić, Simeon L. and Krizakova, Martina and Katrlik, Jaroslav and Nedić, Olgica",
year = "2018",
abstract = "Cirrhosis is a disease which may develop as a consequence of various conditions. In advanced liver disease, blood coagulation can be seriously affected. Portal hypertension, vascular abnormalities and/or a dysbalance in coagulation factors may result in bleeding disorders or in the development of thrombosis. Fibrinogen is the main protein involved in clot formation and wound healing. The aim of this work was to analyse the glycosylation pattern of the isolated fibrinogen molecules by lectin-based protein microarray, together with the carbonylation pattern of the individual fibrinogen chains, possible changes in the molecular secondary and tertiary structure and reactivity with the insulin-like growth factor-binding protein 1 (IGFBP-1) in patients with cirrhosis. The results pointed to an increase in several carbohydrate moieties: tri/tetra-antennary structures, Gal beta-1,4 GlcNAc, terminal alpha-2,3 Sia and alpha-1,3 Man, and a decrease in core alpha-1,6 Fuc and bi-antennary galactosylated N-glycans with bisecting GlcNAc. Fibrinogen A alpha chain was the most susceptible to carbonylation, followed by the B beta chain. Cirrhosis induced additional protein carbonylation, mostly on the alpha chain. Spectrofluorimetry and CD spectrometry detected reduction in the alpha-helix content, protein unfolding and/or appearance of modified amino acid residues in cirrhosis. The amount of complexes which fibrinogen forms with IGFBP-1, another factor involved in wound healing was significantly greater in patients with cirrhosis than in healthy individuals. A more detailed knowledge of individual molecules in coagulation process may contribute to deeper understanding of coagulopathies and the results of this study offer additional information on the possible mechanisms involved in impaired coagulation due to cirrhosis.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "Structural changes of fibrinogen as a consequence of cirrhosis",
volume = "166",
pages = "43-49",
doi = "10.1016/j.thromres.2018.04.005"
}
Gligorijević, N., Minić, S. L., Krizakova, M., Katrlik, J.,& Nedić, O.. (2018). Structural changes of fibrinogen as a consequence of cirrhosis. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 166, 43-49.
https://doi.org/10.1016/j.thromres.2018.04.005
Gligorijević N, Minić SL, Krizakova M, Katrlik J, Nedić O. Structural changes of fibrinogen as a consequence of cirrhosis. in Thrombosis Research. 2018;166:43-49.
doi:10.1016/j.thromres.2018.04.005 .
Gligorijević, Nikola, Minić, Simeon L., Krizakova, Martina, Katrlik, Jaroslav, Nedić, Olgica, "Structural changes of fibrinogen as a consequence of cirrhosis" in Thrombosis Research, 166 (2018):43-49,
https://doi.org/10.1016/j.thromres.2018.04.005 . .
11
4
11
10

Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju

Gligorijević, Nikola

(Универзитет у Београду, Хемијски факултет, 2018)

TY  - THES
AU  - Gligorijević, Nikola
PY  - 2018
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=6386
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:19076/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=50770447
UR  - http://nardus.mpn.gov.rs/123456789/10480
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3162
AB  - Fibrinogen je vaţan protein primarne i glavni protein sekundarne hemostaze. Nakon povrede, on se dejstvom trombina pretvara u nerastvorni fibrin koji se dalje umreţava, pri čemu nastaje fibrinska mreţa koja ojačava krvni ugrušak na mestu povrede. Da bi fibrinogen obavljao svoju biohemijsku ulogu, bitni su odreĎeni faktori, u koje spadaju njegove posttranslacione modifikacije i interakcije sa drugim proteinima. Posttranslacione modifikacije fibrinogena utiču na njegovu strukturu, strukturu fibrina i interakcije sa drugim proteinima. Fibrin nije pasivna mreţa koja samo daje potporu krvnom ugrušku, već je aktivna struktura koja reguliše svoju sintezu i razgradnju interakcijom sa brojnim proteinima. Zato je vaţno otkriti nove proteine koji sa njim interaguju, a koji imaju uticaj na proces zarastanja povreda.U okviru ove diseretacije, optimizovana je procedura za izolovanje i analizu fibrinogena. Upotrebom dvostrukog taloţenja etanolom dobijen je visoko prečišćen fibrinogen, pogodan za dalju karakterizaciju.Kako je poznato da fibrinogen interaguje sa IGFBP-3 proteinom, postavilo se pitanje da li još neki protein iz grupe vezujućih proteina za IGF, pri fiziološkim uslovima, ima tu sposobnost. Upotrebom većeg broja afinitetnih metoda je pokazano da IGFBP-1 interaguje sa fibrinogenom i da je to opšta fiziološka pojava. Značaj ove interakcije treba sagledavati imajući u vidu da i IGFBP-1 podstiče zarastanje tkivnih povreda, samostalno i kao transporter IGF molekula.Brojne patologije pri kojima se javljaju i koagulopatije, kao što su dijabetes melitus tipa 2 i ciroza jetre, karakteriše izmenjena koncentracija i struktura fibrinogena, što za posledicu ima stvaranje abnormalnog, trombogenog fibrina. Detaljno izučavanje pojedinačnih proteina uključenih u koagulopatiju moţe dati bliţu sliku mehanizma odgovornog za ovu pojavu. Sa druge strane, promene na nivou posttranslacionih modifikacija i strukture fibrinogena sa starenjem mogu doprineti boljem razumevanju prisustva ili odsustva odreĎenih patologija kod starijih ljudi.Struktura fibrinogena sa starenjem se menja. Primenom lektinskog eseja uočeno je povećanje visoko-manoznih i/ili hibridnih N-glikana, tri-/tertaantenarnih kompleksnih glikana sa većim sadrţajem Gal i GlcNAc. Spektrofluorimetrijska analiza je pokazala da kod zdravih ljudi preko 60 godina starosti, fibrinogen ima kompaktniju tercijarnustrukturu...
AB  - Fibrinogen is an important protein of primary and main protein of secondary hemostasis. Upon injury, fibrinogen is converted to insoluble fibrin by the action of thrombin. Fibrin further cross-links and creates fibrin network which reinforces blood clotting at the site of injury. There is a significant contribution of posttranslational modifications as well as interactions with other proteins necessary for fulfillment of fibrinogen biochemical role. Posttranslational modifications of fibrinogen influence its structure, fibrin structure and interactions with other proteins. Fibrin is not only a passive network that supports blood clot, but also an active structure that regulates its synthesis and degradation by interacting with many different proteins. For this reason, it is important to identify new proteins which interact with fibrinogen and may also have a role in wound healing.The procedure for isolation and analysis of fibrinogen was optimized in this dissertation. Application of double precipitation using ethanol resulted in highly purified fibrinogen, suitable for further characterisation.Since it is known that fibrinogen interacts with IGFBP-3 protein, the question was raised weather some other protein from the family of the IGF-binding proteins has this ability under physiological conditions. By using several affinity methods, it was shown that IGFBP-1 interacts with fibrinogen and this is a general physiological event. The significance of this interaction should be evaluated taking into consideration that IGFBP-1 itself may have beneficial effect on tissue wound healing, alone and as a transporter of the IGF molecule.Several pathologies accompanied by coagulopathies, such as diabetes mellitus type 2 and cirrhosis, are characterised by altered concentration and structure of fibrinogen, which in turn creates abnormal, thrombogenic fibrin. Detailed study of individual proteins included in coagulopathy may enable closer look at mechanisms responsible for this outcome. On the other hand, changes in posttranslational modifications and structure of fibrinogen with aging may lead to better understanding of presence or absence of certain pathologies associated with ageing.The structure of fibrinogen alteres with aging. An increase of high-mannose and/or hybrid N-glycans, tri-/tetraantennary complex glycans with greater amounts ofGal and GlcNAc was detected by lectin array...
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju
UR  - https://hdl.handle.net/21.15107/rcub_nardus_10480
ER  - 
@phdthesis{
author = "Gligorijević, Nikola",
year = "2018",
abstract = "Fibrinogen je vaţan protein primarne i glavni protein sekundarne hemostaze. Nakon povrede, on se dejstvom trombina pretvara u nerastvorni fibrin koji se dalje umreţava, pri čemu nastaje fibrinska mreţa koja ojačava krvni ugrušak na mestu povrede. Da bi fibrinogen obavljao svoju biohemijsku ulogu, bitni su odreĎeni faktori, u koje spadaju njegove posttranslacione modifikacije i interakcije sa drugim proteinima. Posttranslacione modifikacije fibrinogena utiču na njegovu strukturu, strukturu fibrina i interakcije sa drugim proteinima. Fibrin nije pasivna mreţa koja samo daje potporu krvnom ugrušku, već je aktivna struktura koja reguliše svoju sintezu i razgradnju interakcijom sa brojnim proteinima. Zato je vaţno otkriti nove proteine koji sa njim interaguju, a koji imaju uticaj na proces zarastanja povreda.U okviru ove diseretacije, optimizovana je procedura za izolovanje i analizu fibrinogena. Upotrebom dvostrukog taloţenja etanolom dobijen je visoko prečišćen fibrinogen, pogodan za dalju karakterizaciju.Kako je poznato da fibrinogen interaguje sa IGFBP-3 proteinom, postavilo se pitanje da li još neki protein iz grupe vezujućih proteina za IGF, pri fiziološkim uslovima, ima tu sposobnost. Upotrebom većeg broja afinitetnih metoda je pokazano da IGFBP-1 interaguje sa fibrinogenom i da je to opšta fiziološka pojava. Značaj ove interakcije treba sagledavati imajući u vidu da i IGFBP-1 podstiče zarastanje tkivnih povreda, samostalno i kao transporter IGF molekula.Brojne patologije pri kojima se javljaju i koagulopatije, kao što su dijabetes melitus tipa 2 i ciroza jetre, karakteriše izmenjena koncentracija i struktura fibrinogena, što za posledicu ima stvaranje abnormalnog, trombogenog fibrina. Detaljno izučavanje pojedinačnih proteina uključenih u koagulopatiju moţe dati bliţu sliku mehanizma odgovornog za ovu pojavu. Sa druge strane, promene na nivou posttranslacionih modifikacija i strukture fibrinogena sa starenjem mogu doprineti boljem razumevanju prisustva ili odsustva odreĎenih patologija kod starijih ljudi.Struktura fibrinogena sa starenjem se menja. Primenom lektinskog eseja uočeno je povećanje visoko-manoznih i/ili hibridnih N-glikana, tri-/tertaantenarnih kompleksnih glikana sa većim sadrţajem Gal i GlcNAc. Spektrofluorimetrijska analiza je pokazala da kod zdravih ljudi preko 60 godina starosti, fibrinogen ima kompaktniju tercijarnustrukturu..., Fibrinogen is an important protein of primary and main protein of secondary hemostasis. Upon injury, fibrinogen is converted to insoluble fibrin by the action of thrombin. Fibrin further cross-links and creates fibrin network which reinforces blood clotting at the site of injury. There is a significant contribution of posttranslational modifications as well as interactions with other proteins necessary for fulfillment of fibrinogen biochemical role. Posttranslational modifications of fibrinogen influence its structure, fibrin structure and interactions with other proteins. Fibrin is not only a passive network that supports blood clot, but also an active structure that regulates its synthesis and degradation by interacting with many different proteins. For this reason, it is important to identify new proteins which interact with fibrinogen and may also have a role in wound healing.The procedure for isolation and analysis of fibrinogen was optimized in this dissertation. Application of double precipitation using ethanol resulted in highly purified fibrinogen, suitable for further characterisation.Since it is known that fibrinogen interacts with IGFBP-3 protein, the question was raised weather some other protein from the family of the IGF-binding proteins has this ability under physiological conditions. By using several affinity methods, it was shown that IGFBP-1 interacts with fibrinogen and this is a general physiological event. The significance of this interaction should be evaluated taking into consideration that IGFBP-1 itself may have beneficial effect on tissue wound healing, alone and as a transporter of the IGF molecule.Several pathologies accompanied by coagulopathies, such as diabetes mellitus type 2 and cirrhosis, are characterised by altered concentration and structure of fibrinogen, which in turn creates abnormal, thrombogenic fibrin. Detailed study of individual proteins included in coagulopathy may enable closer look at mechanisms responsible for this outcome. On the other hand, changes in posttranslational modifications and structure of fibrinogen with aging may lead to better understanding of presence or absence of certain pathologies associated with ageing.The structure of fibrinogen alteres with aging. An increase of high-mannose and/or hybrid N-glycans, tri-/tetraantennary complex glycans with greater amounts ofGal and GlcNAc was detected by lectin array...",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju",
url = "https://hdl.handle.net/21.15107/rcub_nardus_10480"
}
Gligorijević, N.. (2018). Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_10480
Gligorijević N. Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju. in Универзитет у Београду. 2018;.
https://hdl.handle.net/21.15107/rcub_nardus_10480 .
Gligorijević, Nikola, "Uticaj posttranslacionih modifikacija fibrinogena na njegovu reaktivnost i funkciju" in Универзитет у Београду (2018),
https://hdl.handle.net/21.15107/rcub_nardus_10480 .

Structural changes of fibrinogen as a consequence of cirrhosis

Gligorijević, Nikola; Minić, Simeon L.; Krizakova, Martina; Katrlik, Jaroslav; Nedić, Olgica

(Pergamon-Elsevier Science Ltd, Oxford, 2018)

TY  - JOUR
AU  - Gligorijević, Nikola
AU  - Minić, Simeon L.
AU  - Krizakova, Martina
AU  - Katrlik, Jaroslav
AU  - Nedić, Olgica
PY  - 2018
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3265
AB  - Cirrhosis is a disease which may develop as a consequence of various conditions. In advanced liver disease, blood coagulation can be seriously affected. Portal hypertension, vascular abnormalities and/or a dysbalance in coagulation factors may result in bleeding disorders or in the development of thrombosis. Fibrinogen is the main protein involved in clot formation and wound healing. The aim of this work was to analyse the glycosylation pattern of the isolated fibrinogen molecules by lectin-based protein microarray, together with the carbonylation pattern of the individual fibrinogen chains, possible changes in the molecular secondary and tertiary structure and reactivity with the insulin-like growth factor-binding protein 1 (IGFBP-1) in patients with cirrhosis. The results pointed to an increase in several carbohydrate moieties: tri/tetra-antennary structures, Gal beta-1,4 GlcNAc, terminal alpha-2,3 Sia and alpha-1,3 Man, and a decrease in core alpha-1,6 Fuc and bi-antennary galactosylated N-glycans with bisecting GlcNAc. Fibrinogen A alpha chain was the most susceptible to carbonylation, followed by the B beta chain. Cirrhosis induced additional protein carbonylation, mostly on the alpha chain. Spectrofluorimetry and CD spectrometry detected reduction in the alpha-helix content, protein unfolding and/or appearance of modified amino acid residues in cirrhosis. The amount of complexes which fibrinogen forms with IGFBP-1, another factor involved in wound healing was significantly greater in patients with cirrhosis than in healthy individuals. A more detailed knowledge of individual molecules in coagulation process may contribute to deeper understanding of coagulopathies and the results of this study offer additional information on the possible mechanisms involved in impaired coagulation due to cirrhosis.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - Structural changes of fibrinogen as a consequence of cirrhosis
VL  - 166
SP  - 43
EP  - 49
DO  - 10.1016/j.thromres.2018.04.005
ER  - 
@article{
author = "Gligorijević, Nikola and Minić, Simeon L. and Krizakova, Martina and Katrlik, Jaroslav and Nedić, Olgica",
year = "2018",
abstract = "Cirrhosis is a disease which may develop as a consequence of various conditions. In advanced liver disease, blood coagulation can be seriously affected. Portal hypertension, vascular abnormalities and/or a dysbalance in coagulation factors may result in bleeding disorders or in the development of thrombosis. Fibrinogen is the main protein involved in clot formation and wound healing. The aim of this work was to analyse the glycosylation pattern of the isolated fibrinogen molecules by lectin-based protein microarray, together with the carbonylation pattern of the individual fibrinogen chains, possible changes in the molecular secondary and tertiary structure and reactivity with the insulin-like growth factor-binding protein 1 (IGFBP-1) in patients with cirrhosis. The results pointed to an increase in several carbohydrate moieties: tri/tetra-antennary structures, Gal beta-1,4 GlcNAc, terminal alpha-2,3 Sia and alpha-1,3 Man, and a decrease in core alpha-1,6 Fuc and bi-antennary galactosylated N-glycans with bisecting GlcNAc. Fibrinogen A alpha chain was the most susceptible to carbonylation, followed by the B beta chain. Cirrhosis induced additional protein carbonylation, mostly on the alpha chain. Spectrofluorimetry and CD spectrometry detected reduction in the alpha-helix content, protein unfolding and/or appearance of modified amino acid residues in cirrhosis. The amount of complexes which fibrinogen forms with IGFBP-1, another factor involved in wound healing was significantly greater in patients with cirrhosis than in healthy individuals. A more detailed knowledge of individual molecules in coagulation process may contribute to deeper understanding of coagulopathies and the results of this study offer additional information on the possible mechanisms involved in impaired coagulation due to cirrhosis.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "Structural changes of fibrinogen as a consequence of cirrhosis",
volume = "166",
pages = "43-49",
doi = "10.1016/j.thromres.2018.04.005"
}
Gligorijević, N., Minić, S. L., Krizakova, M., Katrlik, J.,& Nedić, O.. (2018). Structural changes of fibrinogen as a consequence of cirrhosis. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 166, 43-49.
https://doi.org/10.1016/j.thromres.2018.04.005
Gligorijević N, Minić SL, Krizakova M, Katrlik J, Nedić O. Structural changes of fibrinogen as a consequence of cirrhosis. in Thrombosis Research. 2018;166:43-49.
doi:10.1016/j.thromres.2018.04.005 .
Gligorijević, Nikola, Minić, Simeon L., Krizakova, Martina, Katrlik, Jaroslav, Nedić, Olgica, "Structural changes of fibrinogen as a consequence of cirrhosis" in Thrombosis Research, 166 (2018):43-49,
https://doi.org/10.1016/j.thromres.2018.04.005 . .
11
4
10
10

Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима

Šunderić, Miloš B.

(Универзитет у Београду, Хемијски факултет, 2016)

TY  - THES
AU  - Šunderić, Miloš B.
PY  - 2016
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=3757
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:12658/bdef:Content/download
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:12770/bdef:Izvestaj/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=48021519
UR  - http://nardus.mpn.gov.rs/123456789/6474
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2705
AB  - Везујући протеин 2 за факторе раста сличне инсулину (IGFBP-2) у циркулацији се може јавити у три облика: као комплекс, мономер и фрагмент различитих молекулских маса. У оквиру ове докторске дисертације је утврђено да IGFBP-2 гради комплексе са α-2-макроглобулином (α2М).Релативни удео комплекса IGFBP-2/α2М у укупном IGFBP-2 не зависи директно од концентрације IGFBP-2 и α2М, већ зависи од различитих (пато)физиолошкихуслова у којима се организам налази. У овом раду су испитане различите методе за изоловање, мерење и карактеризацију комплекса IGFBP-2/α2М. Такође је испитана промена и могућа улога комплекса код пацијената са тумором.Познато је да мономер IGFBP-2 везује IGF лиганде са великим афинитетом и транспортује их до ткива где се, након протеолизе IGFBP-2, отпуштају и везују за специфичне ћелијске рецепторе. Осим као носач IGF пептида, IGFBP-2 испољава и независна метаболичка и митогена дејства. Везујући се за интегринске рецепторе (првенствено за α5β1), IGFBP-2 стимулише покретљивост ћелије и њено одвајање од околине, доприносећи метастатском потенцијалу. Неки фрагменти могу слабо везати IGF лиганде и интераговати са ћелијама. О комплексима IGFBP-2 у циркулацији до сада није било података у литератури.У раду је показано да се врста молекулских облика IGFBP-2 не мења под утицајем различитих (пато)физиолошких фактора, као што су старење, активно бављење спортом, оксидативни стрес, повећанa концентрацијa липида или глукозе, измењена протеолитичка активност, али се мења њихова количина и међусобни однос. Старењем се повећава концентрација мономера и фрагмената IGFBP-2 у циркулацији, као и α2М, а смањује се концентрација комплекса IGFBP-2/α2М. Јони цинка (II) подстичу олигомеризацију α2M, али не утичу на стварање комплекса. Пептидна секвенца RGD, која је важна за интеракцију IGFBP-2 са интегрином, није контактна секвенца за интеракцију IGFBP-2 са α2М.Код пацијената са тумором дебелог црева је измерена повећана концентрација укупног IGFBP-2 у циркулацији у односу на здраве људе, као и измењен међусобни однос молекулских форми. Повећана је концентрација мономера и фрагмената, а смањена комплекса. У ткиву дебелог црева су нађени само мономер и фрагменти...
AB  - In circulation, insulin-like growth factor binding protein 2 (IGFBP-2), can be found in three main forms: as a complex, monomer and assembley of fragments of differents molecular masses. In making this dissertation it was found that IGFBP-2 forms complexes with α-2-macroglobulin (α2M).Relative amount of IGFBP-2/α2M complex in total IGFBP-2 concentration does not depend on concentrations of IGFBP-2 and α2M, but from various (patho)physiological conditions in organism. In this work, different methods for isolation, measurement and characterisation of IGFBP-2/α2M complex were examined. An investigation on potential role of these complexes in patients with tumor was also conducted.It is known that IGFBP-2 monomer binds IGF ligands with high affinity and transports them to tissues where, after proteolysis, they are released, and bound to specific receptors. Except being the IGF carrier, IGFBP-2 exerts IGF-independent metabolic and mitogenic actions. It can bind to integrin receptors (primarily to α5β1) and stimulate cell motility and detachement from their surroundings, contributing to metastatic potential. Some fragments can loosely bind IGF ligands and interact with cells. Until know, there was no literature data about IGFBP-2 complexes in circulation.In this work, it was shown that the distribution of molecular species of IGFBP-2 does not change under the influence of different (patho)physiological factors, such as aging, intensive physical activity, oxidative stress, increased concentration of lipids and glucose, impaired proteolytic activity, but by the quantity and their mutual ratio change. With aging, the concentration of IGFBP-2 monomers and fragments, and α2M, in circulation increases, while the concentration of IGFBP-2/α2M complex decreases. Zinc ions encourage the α2M oligomerisation, but have no influence on complex formation. RGD peptide sequence, which is important for IGFBP-2 interaction with integrins, is not a contact sequence for interaction between IGFBP-2 and α2M.In serum of patients with colon cancer, increased concentration of IGFBP-2 was detected, as well as different relation of molecular forms. The concentration of monomer and fragments increased, while the concentration of complexes decreased...
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима
T1  - Molecular forms of IGF binding protein 2 and their presence in various pathophysiological states
UR  - https://hdl.handle.net/21.15107/rcub_nardus_6474
ER  - 
@phdthesis{
author = "Šunderić, Miloš B.",
year = "2016",
abstract = "Везујући протеин 2 за факторе раста сличне инсулину (IGFBP-2) у циркулацији се може јавити у три облика: као комплекс, мономер и фрагмент различитих молекулских маса. У оквиру ове докторске дисертације је утврђено да IGFBP-2 гради комплексе са α-2-макроглобулином (α2М).Релативни удео комплекса IGFBP-2/α2М у укупном IGFBP-2 не зависи директно од концентрације IGFBP-2 и α2М, већ зависи од различитих (пато)физиолошкихуслова у којима се организам налази. У овом раду су испитане различите методе за изоловање, мерење и карактеризацију комплекса IGFBP-2/α2М. Такође је испитана промена и могућа улога комплекса код пацијената са тумором.Познато је да мономер IGFBP-2 везује IGF лиганде са великим афинитетом и транспортује их до ткива где се, након протеолизе IGFBP-2, отпуштају и везују за специфичне ћелијске рецепторе. Осим као носач IGF пептида, IGFBP-2 испољава и независна метаболичка и митогена дејства. Везујући се за интегринске рецепторе (првенствено за α5β1), IGFBP-2 стимулише покретљивост ћелије и њено одвајање од околине, доприносећи метастатском потенцијалу. Неки фрагменти могу слабо везати IGF лиганде и интераговати са ћелијама. О комплексима IGFBP-2 у циркулацији до сада није било података у литератури.У раду је показано да се врста молекулских облика IGFBP-2 не мења под утицајем различитих (пато)физиолошких фактора, као што су старење, активно бављење спортом, оксидативни стрес, повећанa концентрацијa липида или глукозе, измењена протеолитичка активност, али се мења њихова количина и међусобни однос. Старењем се повећава концентрација мономера и фрагмената IGFBP-2 у циркулацији, као и α2М, а смањује се концентрација комплекса IGFBP-2/α2М. Јони цинка (II) подстичу олигомеризацију α2M, али не утичу на стварање комплекса. Пептидна секвенца RGD, која је важна за интеракцију IGFBP-2 са интегрином, није контактна секвенца за интеракцију IGFBP-2 са α2М.Код пацијената са тумором дебелог црева је измерена повећана концентрација укупног IGFBP-2 у циркулацији у односу на здраве људе, као и измењен међусобни однос молекулских форми. Повећана је концентрација мономера и фрагмената, а смањена комплекса. У ткиву дебелог црева су нађени само мономер и фрагменти..., In circulation, insulin-like growth factor binding protein 2 (IGFBP-2), can be found in three main forms: as a complex, monomer and assembley of fragments of differents molecular masses. In making this dissertation it was found that IGFBP-2 forms complexes with α-2-macroglobulin (α2M).Relative amount of IGFBP-2/α2M complex in total IGFBP-2 concentration does not depend on concentrations of IGFBP-2 and α2M, but from various (patho)physiological conditions in organism. In this work, different methods for isolation, measurement and characterisation of IGFBP-2/α2M complex were examined. An investigation on potential role of these complexes in patients with tumor was also conducted.It is known that IGFBP-2 monomer binds IGF ligands with high affinity and transports them to tissues where, after proteolysis, they are released, and bound to specific receptors. Except being the IGF carrier, IGFBP-2 exerts IGF-independent metabolic and mitogenic actions. It can bind to integrin receptors (primarily to α5β1) and stimulate cell motility and detachement from their surroundings, contributing to metastatic potential. Some fragments can loosely bind IGF ligands and interact with cells. Until know, there was no literature data about IGFBP-2 complexes in circulation.In this work, it was shown that the distribution of molecular species of IGFBP-2 does not change under the influence of different (patho)physiological factors, such as aging, intensive physical activity, oxidative stress, increased concentration of lipids and glucose, impaired proteolytic activity, but by the quantity and their mutual ratio change. With aging, the concentration of IGFBP-2 monomers and fragments, and α2M, in circulation increases, while the concentration of IGFBP-2/α2M complex decreases. Zinc ions encourage the α2M oligomerisation, but have no influence on complex formation. RGD peptide sequence, which is important for IGFBP-2 interaction with integrins, is not a contact sequence for interaction between IGFBP-2 and α2M.In serum of patients with colon cancer, increased concentration of IGFBP-2 was detected, as well as different relation of molecular forms. The concentration of monomer and fragments increased, while the concentration of complexes decreased...",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима, Molecular forms of IGF binding protein 2 and their presence in various pathophysiological states",
url = "https://hdl.handle.net/21.15107/rcub_nardus_6474"
}
Šunderić, M. B.. (2016). Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_6474
Šunderić MB. Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима. in Универзитет у Београду. 2016;.
https://hdl.handle.net/21.15107/rcub_nardus_6474 .
Šunderić, Miloš B., "Молекулски облици везујућег протеина 2 за факторе раста сличне инсулину и њихова заступљеност у различитим патофизиолошким стањима" in Универзитет у Београду (2016),
https://hdl.handle.net/21.15107/rcub_nardus_6474 .

N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima

Robajac, Dragana B.

(Универзитет у Београду, Хемијски факултет, 2016)

TY  - THES
AU  - Robajac, Dragana B.
PY  - 2016
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=3653
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:12455/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=48133135
UR  - http://nardus.mpn.gov.rs/123456789/6381
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2699
AB  - Funkcije membranskih proteina su brojne: međućelijska komunikacija, adhezija, signalna transdukcija. Većina membranskih proteina je glikozilovana i N-glikani imaju važnu ulogu u formiranju trodimenzionalne strukture membranskih proteina, kao i u ispoljavanju njihove funkcije. Receptori za insulin (IR) i faktor rasta sličan insulinu tip 1 (IGF1R) su transmembranske tirozin-kinaze sa visokim stepenom homologije (u nekim domenima čak i 80%). Familija IGF receptora, pored IR i IGF1R, uključuje i receptor za faktore rasta slične insulinu tip 2 (IGF2R). Sva tri receptora (IR, IGF1R i IGF2R) su glikozilovani i obilno prisutni u placenti, gde imaju važne uloge u njenom razvoju i funkcionisanju.Placenta raste i razvija se da bi ispunila različite potrebe fetusa, pa se struktura i funkcija placente menjaju tokom gestacije. Znajući da su proteini odgovorni za biološke funkcije placente pretpostavljeno je da tokom gestacije može doći i do promene u sadržaju različitih tipova N-glikana prisutnih na membranskim proteinima. U ovoj tezi analizirani su tipovi N-glikana koji se mogu naći u sastavu membranskih glikoproteina, odnosno membranski N-glikom proteina humane placente. Ispitana je podložnost membranskog N-glikoma individualnim varijacijama i uticaju starosti majke/trudnice, kao i uticaj gestacije na membranski N-glikom. Znajući da je izmenjena glikozilacija često povezana sa izmenjenom funkcijom, kao i da izmenjena funkcija jednog ili više proteina može biti uzrok bolesti, ispitane su potencijalne promene membranskog N-glikoma u patološkim trudnoćama (kod preeklampsije) i trudnoćama komplikovanim patologijom majki (dijabetes). Uporedo je ispitan i uticaj starosti, gestacije i patologije na tip i zastupljenost različitih N-glikana koji ulaze u sastav receptora IGF sistema. Cilj je bio da se ispita da li promene na ukupnim membranskim proteinima (na N-glikomu) prate promene N-glikana prisutnih na pojedinačnim membranskim glikoproteinima važnim za rast i funkcionisanje placente...
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima
T1  - N-glycome of membrane proteins and receptors for insulin and insulin-like growth factors, isolated from human placenta at different (patho)physiological states
UR  - https://hdl.handle.net/21.15107/rcub_nardus_6381
ER  - 
@phdthesis{
author = "Robajac, Dragana B.",
year = "2016",
abstract = "Funkcije membranskih proteina su brojne: međućelijska komunikacija, adhezija, signalna transdukcija. Većina membranskih proteina je glikozilovana i N-glikani imaju važnu ulogu u formiranju trodimenzionalne strukture membranskih proteina, kao i u ispoljavanju njihove funkcije. Receptori za insulin (IR) i faktor rasta sličan insulinu tip 1 (IGF1R) su transmembranske tirozin-kinaze sa visokim stepenom homologije (u nekim domenima čak i 80%). Familija IGF receptora, pored IR i IGF1R, uključuje i receptor za faktore rasta slične insulinu tip 2 (IGF2R). Sva tri receptora (IR, IGF1R i IGF2R) su glikozilovani i obilno prisutni u placenti, gde imaju važne uloge u njenom razvoju i funkcionisanju.Placenta raste i razvija se da bi ispunila različite potrebe fetusa, pa se struktura i funkcija placente menjaju tokom gestacije. Znajući da su proteini odgovorni za biološke funkcije placente pretpostavljeno je da tokom gestacije može doći i do promene u sadržaju različitih tipova N-glikana prisutnih na membranskim proteinima. U ovoj tezi analizirani su tipovi N-glikana koji se mogu naći u sastavu membranskih glikoproteina, odnosno membranski N-glikom proteina humane placente. Ispitana je podložnost membranskog N-glikoma individualnim varijacijama i uticaju starosti majke/trudnice, kao i uticaj gestacije na membranski N-glikom. Znajući da je izmenjena glikozilacija često povezana sa izmenjenom funkcijom, kao i da izmenjena funkcija jednog ili više proteina može biti uzrok bolesti, ispitane su potencijalne promene membranskog N-glikoma u patološkim trudnoćama (kod preeklampsije) i trudnoćama komplikovanim patologijom majki (dijabetes). Uporedo je ispitan i uticaj starosti, gestacije i patologije na tip i zastupljenost različitih N-glikana koji ulaze u sastav receptora IGF sistema. Cilj je bio da se ispita da li promene na ukupnim membranskim proteinima (na N-glikomu) prate promene N-glikana prisutnih na pojedinačnim membranskim glikoproteinima važnim za rast i funkcionisanje placente...",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima, N-glycome of membrane proteins and receptors for insulin and insulin-like growth factors, isolated from human placenta at different (patho)physiological states",
url = "https://hdl.handle.net/21.15107/rcub_nardus_6381"
}
Robajac, D. B.. (2016). N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_6381
Robajac DB. N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima. in Универзитет у Београду. 2016;.
https://hdl.handle.net/21.15107/rcub_nardus_6381 .
Robajac, Dragana B., "N-glikom membranskih proteina i receptora za insulin i faktore rasta slične insulinu, izolovanih iz humane placente u različitim (pato)fiziološkim stanjima" in Универзитет у Београду (2016),
https://hdl.handle.net/21.15107/rcub_nardus_6381 .

Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu

Miljuš, Goran M.

(Универзитет у Београду, Хемијски факултет, 2015)

TY  - THES
AU  - Miljuš, Goran M.
PY  - 2015
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=3188
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:11551/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=47672079
UR  - http://nardus.mpn.gov.rs/123456789/5893
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2678
AB  - Sistem faktora rasta, po strukturi i funkciji, sličnih insulinu („insulin-like growth factor“- IGF) obuhvata elemente sa primarnom ulogom u regulaciji rasta, razvoja, diferencijacije ćelija kako u fiziološkim, tako i u patofiziološkim uslovima. Pored dva funkcionalna peptidna hormona, IGF-I i IGF-II, ovaj sistem sadrži molekule koji regulišu ispoljavanje njihove fiziološke funkcije. Regulatorni elementi IGF sistema su: vezujući proteini (IGFBP-1 do -6), receptori za IGF molekule: IGF-1R, IGF-2R, insulinski receptor (IR), hibridni receptor IGF-R/IR, kao i specifične proteaze. Nakon proteolize IGFBP, funkcija IGF-I/II se ispoljava interakcijom sa IGF specifičnim receptorima na površini ćelija.U kompleksu sa IGFBP-3 se nalazi 70-75% IGF peptida. Pored primarne uloge nosača IGF molekula, IGFBP-3 učestvuje i u brojnim interakcijama nezavisno od IGF. IGFBP-3 poseduje više strukturnih domena što ga čini sposobnim za vezivanje za druge molekule i pokretanje signalnih puteva i mehanizama nezavisnih, a nekad i suprotnih, dejstvu IGF peptida poput stimulacije rasta ćelija ili pokretanja apoptotskih procesa. Jedan od partnera koji interaguje sa IGFBP-3 je transferin (Tf), glavni transporter jona gvožđa u krvi.Iako se za postojanje kompleksa IGFBP-3/Tf znalo i ranije, rezultati ove disertacije predstavljaju prvi prikaz strukturnih i funkcionalnih osobina ovih kompleksa, kao i sagledavanje njihove moguće uloge. U ovoj disertaciji je opisan optimizovan postupak za izolovanje kompleksa iz fizioloških uzoraka (seruma i tkiva), navedene su strukturne karakteristike kompleksa IGFBP-3/Tf, faktori koji utiču na njihovo formiranje, određena je koncentracija kompleksa u serumu zdravih odraslih osoba i osoba sa poremećajem u metabolizmu gvožđa, dokazana je neophodnost jona gvožđa za formiranje kompleksa i analizirana je subćelijska raspodela kompleksa u tkivu debelog creva (zdravog i tumorskog). U radu je ispitan uticaj: anemije, visoke koncentracije gvožđa i tumora debelog creva, na koncentraciju i strukturu kompleksa. Za tumor debelog creva je karakteristična sistemska anemija, praćena akumulacijom gvožđa u samom tumorskom tkivu. Na model sistemu tumora debelog creva ispitana je važnost puta internalizacije IGFBP-3 preko kompleksa sa Tf, odnosno posredstvom transferinskog receptora (TfR).Nađeno je da je koncentracija kompleksa IGFBP-3/Tf kod zdravih ljudi 241 ± 62 μg/L i da se u ovoj formi nalazi 5-7% ukupnog IGFBP-3. Kod različitih patofizioloških stanja sa poremećajem u metabolizmu gvožđa utvrđeno je da formiranje kompleksa primarno zavisi od koncentracije gvožđa, potom koncetracije IGFBP-3, ali i proteina uključenih u metabolizam gvožđa, poput feritina. Kod IGFBP-3/Tf kompleksa analiziranih u uzorcima seruma dobijenih od pacijenata sa tumorom debelog creva primećen je izmenjen način...
AB  - The insulin-like growth factor (IGF) system plays an important role in the regulation of cell growth, development and differentiation, in both physiological and pathophysiological condition. Beside two peptide hormones IGF-I and IGF-II, this system includes the following regulatory elements: six IGF-binding proteins (IGFBP-1 to -6), specific receptors for IGF (IGF-1R and IGF-2R), insulin receptor (IR), hybrid receptor (IGF-R/IR) as well as IGFBP specific proteases. When IGFBPs are proteolytically cleaved, IGF-I/II are able to exert their physiological function by interacting with specific receptors on the cell surface.Approximately 70-75% of the total IGFs, are transported in circulation in the form of ternary complexes with IGFBP-3. Besides being the principal carrier of IGF molecules, IGFBP-3 was reported to exert a number of activities which are IGF-independent. Due to its structural sub-domain organisation, this molecule is able to interact with binding partners other than IGFs, and consequently activate mechanisms and signaling cascades with independent or even opposite effects to those of IGF-I/II, such as apoptosis. One of these binding partners is transferrin (Tf), the principal iron transporter in the blood.Although the existence of IGFBP-3/Tf complexes has already been reported, the results presented in this thesis offer the first complete structural and functional characterisation of the complexes, together with the analysis of their potential role. The fully optimised method for the isolation of intact IGFBP-3/Tf complexes from serum and tissue samples has been described, some structural characteristics have been defined, the effect of iron and other factors on the formation of complexes was studied, their concentration in sera from healthy persons and patients with impaired iron metabolism disorders was measured, as well as their subcellular distribution in colon tissue (healthy and tumor tissue). The formation and concentration of IGFBP-3/Tf complexes in persons with anemia, persons with very high iron concentration or patients with colorectal carcinoma (CRC) have also been investigated. The emphasis was made on samples from patients with CRC, a disease accompanied by systemic anemia and increased iron accumulation in cancer cells. CRC was a model system for the analysis of IGFBP-3 internalisation via Tf-TfR pathway.The concentration of IGFBP-3/Tf complexes in healthy adults was measured to be 241 ± 62 μg/L, which makes up to 5-7% of the total IGFBP-3. The results have shown that in impaired iron metabolism, the formation of complexes is highly dependent on the iron concentration, then IGFBP-3 concentration, as well as the concentration of other proteins involved in iron metabolism, such as ferritin. IGFBP-3/Tf complexes isolated form serum...
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu
T1  - Isolation, characterisation and the role of complexes formed between transferrin and insulin-like growth factor-binding protein 3
UR  - https://hdl.handle.net/21.15107/rcub_nardus_5893
ER  - 
@phdthesis{
author = "Miljuš, Goran M.",
year = "2015",
abstract = "Sistem faktora rasta, po strukturi i funkciji, sličnih insulinu („insulin-like growth factor“- IGF) obuhvata elemente sa primarnom ulogom u regulaciji rasta, razvoja, diferencijacije ćelija kako u fiziološkim, tako i u patofiziološkim uslovima. Pored dva funkcionalna peptidna hormona, IGF-I i IGF-II, ovaj sistem sadrži molekule koji regulišu ispoljavanje njihove fiziološke funkcije. Regulatorni elementi IGF sistema su: vezujući proteini (IGFBP-1 do -6), receptori za IGF molekule: IGF-1R, IGF-2R, insulinski receptor (IR), hibridni receptor IGF-R/IR, kao i specifične proteaze. Nakon proteolize IGFBP, funkcija IGF-I/II se ispoljava interakcijom sa IGF specifičnim receptorima na površini ćelija.U kompleksu sa IGFBP-3 se nalazi 70-75% IGF peptida. Pored primarne uloge nosača IGF molekula, IGFBP-3 učestvuje i u brojnim interakcijama nezavisno od IGF. IGFBP-3 poseduje više strukturnih domena što ga čini sposobnim za vezivanje za druge molekule i pokretanje signalnih puteva i mehanizama nezavisnih, a nekad i suprotnih, dejstvu IGF peptida poput stimulacije rasta ćelija ili pokretanja apoptotskih procesa. Jedan od partnera koji interaguje sa IGFBP-3 je transferin (Tf), glavni transporter jona gvožđa u krvi.Iako se za postojanje kompleksa IGFBP-3/Tf znalo i ranije, rezultati ove disertacije predstavljaju prvi prikaz strukturnih i funkcionalnih osobina ovih kompleksa, kao i sagledavanje njihove moguće uloge. U ovoj disertaciji je opisan optimizovan postupak za izolovanje kompleksa iz fizioloških uzoraka (seruma i tkiva), navedene su strukturne karakteristike kompleksa IGFBP-3/Tf, faktori koji utiču na njihovo formiranje, određena je koncentracija kompleksa u serumu zdravih odraslih osoba i osoba sa poremećajem u metabolizmu gvožđa, dokazana je neophodnost jona gvožđa za formiranje kompleksa i analizirana je subćelijska raspodela kompleksa u tkivu debelog creva (zdravog i tumorskog). U radu je ispitan uticaj: anemije, visoke koncentracije gvožđa i tumora debelog creva, na koncentraciju i strukturu kompleksa. Za tumor debelog creva je karakteristična sistemska anemija, praćena akumulacijom gvožđa u samom tumorskom tkivu. Na model sistemu tumora debelog creva ispitana je važnost puta internalizacije IGFBP-3 preko kompleksa sa Tf, odnosno posredstvom transferinskog receptora (TfR).Nađeno je da je koncentracija kompleksa IGFBP-3/Tf kod zdravih ljudi 241 ± 62 μg/L i da se u ovoj formi nalazi 5-7% ukupnog IGFBP-3. Kod različitih patofizioloških stanja sa poremećajem u metabolizmu gvožđa utvrđeno je da formiranje kompleksa primarno zavisi od koncentracije gvožđa, potom koncetracije IGFBP-3, ali i proteina uključenih u metabolizam gvožđa, poput feritina. Kod IGFBP-3/Tf kompleksa analiziranih u uzorcima seruma dobijenih od pacijenata sa tumorom debelog creva primećen je izmenjen način..., The insulin-like growth factor (IGF) system plays an important role in the regulation of cell growth, development and differentiation, in both physiological and pathophysiological condition. Beside two peptide hormones IGF-I and IGF-II, this system includes the following regulatory elements: six IGF-binding proteins (IGFBP-1 to -6), specific receptors for IGF (IGF-1R and IGF-2R), insulin receptor (IR), hybrid receptor (IGF-R/IR) as well as IGFBP specific proteases. When IGFBPs are proteolytically cleaved, IGF-I/II are able to exert their physiological function by interacting with specific receptors on the cell surface.Approximately 70-75% of the total IGFs, are transported in circulation in the form of ternary complexes with IGFBP-3. Besides being the principal carrier of IGF molecules, IGFBP-3 was reported to exert a number of activities which are IGF-independent. Due to its structural sub-domain organisation, this molecule is able to interact with binding partners other than IGFs, and consequently activate mechanisms and signaling cascades with independent or even opposite effects to those of IGF-I/II, such as apoptosis. One of these binding partners is transferrin (Tf), the principal iron transporter in the blood.Although the existence of IGFBP-3/Tf complexes has already been reported, the results presented in this thesis offer the first complete structural and functional characterisation of the complexes, together with the analysis of their potential role. The fully optimised method for the isolation of intact IGFBP-3/Tf complexes from serum and tissue samples has been described, some structural characteristics have been defined, the effect of iron and other factors on the formation of complexes was studied, their concentration in sera from healthy persons and patients with impaired iron metabolism disorders was measured, as well as their subcellular distribution in colon tissue (healthy and tumor tissue). The formation and concentration of IGFBP-3/Tf complexes in persons with anemia, persons with very high iron concentration or patients with colorectal carcinoma (CRC) have also been investigated. The emphasis was made on samples from patients with CRC, a disease accompanied by systemic anemia and increased iron accumulation in cancer cells. CRC was a model system for the analysis of IGFBP-3 internalisation via Tf-TfR pathway.The concentration of IGFBP-3/Tf complexes in healthy adults was measured to be 241 ± 62 μg/L, which makes up to 5-7% of the total IGFBP-3. The results have shown that in impaired iron metabolism, the formation of complexes is highly dependent on the iron concentration, then IGFBP-3 concentration, as well as the concentration of other proteins involved in iron metabolism, such as ferritin. IGFBP-3/Tf complexes isolated form serum...",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu, Isolation, characterisation and the role of complexes formed between transferrin and insulin-like growth factor-binding protein 3",
url = "https://hdl.handle.net/21.15107/rcub_nardus_5893"
}
Miljuš, G. M.. (2015). Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_5893
Miljuš GM. Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu. in Универзитет у Београду. 2015;.
https://hdl.handle.net/21.15107/rcub_nardus_5893 .
Miljuš, Goran M., "Izolovanje, karakterizacija i uloga kompleksa transferina sa vezujućim proteinom 3 za faktore rasta slične insulinu" in Универзитет у Београду (2015),
https://hdl.handle.net/21.15107/rcub_nardus_5893 .

Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze

Lagundžin, Dragana

(Универзитет у Београду, Хемијски факултет, 2014)

TY  - THES
AU  - Lagundžin, Dragana
PY  - 2014
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=3341
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:11813/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=47627791
UR  - http://nardus.mpn.gov.rs/123456789/6036
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2692
AB  - Vezujući proteini za faktore rasta slične insulinu (IGFBP), zajedno sa IGFligandima i IGF receptorima (IGF-1R i IGF-2R) čine sistem koji utiče na rast i razvojskoro svake ćelije, tkiva i organa. IGFBP-1 je jedini od šest IGFBP molekula čija sekoncentracija menja na dnevnoj bazi, u zavisnosti od koncentracije insulina u krvi,odnosno od metaboličkih potreba vezanih za potrošnju glukoze. Kod zdravih osoba jekonstatovano postojanje direktne negativne sprege između koncentracije IGFBP-1 iinsulina, dok se kod osoba sa izmenjenim metabolizmom glukoze ta sprega često gubi.Cilj ovog istraživanja je bio da se ispita da li se i u kojoj meri IGFBP-1 menja posttranslacionoi da li interaguje sa drugim proteinima iz okruženja, što bi moglo doprinetiefektima uočenim na nivou ose IGFBP-1/IGF/insulin kod osoba sa nepravilnimmetabolizmom glukoze ili osoba izloženih metaboličkom opterećenju.Eksperimentalno je utvrđeno postojanje monomera, nekoliko fragmenata,oligomera i kompleksa IGFBP-1. Rezultati su dalje pokazali da se kod osoba saporemećajem u metabolizmu glukoze, kao što su diabetes mellitus ili hipoglikemija,menjaju koncentracije i strukturne karakteristike IGFBP-1. Najintenzivnije posttranslacionepromene IGFBP-1 se javljaju kod pacijenata sa dijabetesom tipa 2.Prisutnost većeg broja različitih molekulskih formi IGFBP-1 kod ovih pacijenata, presvega multimera, ukazuje na potencijalno veće učečće IGF sistema u regulacijikoncentracije glukoze u stanju dijabetesa. Profesionalno bavljenje sportom, takođe,dovodi do promene u koncentraciji i strukturi IGFBP-1. Koncentracija ukupnog IGFBP-1 raste kod sportista ali, usled povećane proteolize, značajno se uvećava udeo IGFBP-1fragmenata. Glavni fragment IGFBP-1 u serumu sportista je mase 9 kDa i, verovatno,nastaje kao posledica povećane aktivnosti matriksne metaloproteaze 9. Primenommasene spektrometrije, kod sportista je ustanovljena izmenjena reaktivnost IGFBP-1 načipovima sa različitim jonoizmenjivačkim površinama, ukazujući na promenu u fizičkohemijskimkarakteristikama IGFBP-1, pre svega u naelektrisanju. Pušenje, kao uzročnikstvaranja slobodnih radikala i dodatni faktor rizika od vaskularnih komplikacija koddijabetičara, prema dobijenim rezultatima, nije od uticaja na oligomerizaciju(oksidaciju) IGFBP-1 u cirkulaciji.Na kraju, opšti zaključak bi bio da promene u metabolizmu glukoze, bez obzirada li su izazvane poremećajima ili povećanom potrebom za glukozom, dovode dopromene u koncentraciji i strukturi IGFBP-1, što se u najvećoj meri iskazuje krozizmenjen stepen oligomerizacije i proteolize IGFBP-1. Proces stvaranja kompleksaIGFBP-1 sa α2-makroglobulinom je najotporniji na uticaje. Pošto oligomeri i fragmentiIGFBP-1 uglavnom ne vezuju IGF ligande, redistribucijom IGFBP-1 između višerazličitih molekulskih formi, u uslovima izmenjenog metabolizma glukoze, može seznatno uticati na stepen vezivanja, odnosno biodostupnosti IGF peptida.
AB  - The insulin-like growth factor binding proteins (IGFBPs), IGF ligands and IGFreceptors (IGF-1R i IGF-2R) comprise a system involved in growth and development ofalmost evey cell, tissue and organ. Among six IGFBPs, IGFBP-1 is the only one thatexhibits diurnal variation and correlates with the level of insulin in blood.Concentrations of IGFBP-1 and insulin are inversely proportional in healthy people.That correlation could be lost in the case of altered glucose metabolism. The aim of thisstudy was to examine whether and to what extent IGFBP-1 changes post-translationallyand whether IGFBP-1 interacts with other proteins in the surrounding that couldcontribute to the effects detected in the IGFBP-1/IGF/insulin axis in persons withimpaired glucose metobolism or in those with hypermetabolism.The existance of IGFBP-1 monomer, several fragments, oligomers andcomplexes was confirmed experimentally. The results have further shown that IGFBP-1concentration and structure undergo certain changes in patients with impaired glucosemetabolism, as in the case of diabetes mellitus and hypoglicemia. The most pronouncedpost-translational modifications of IGFBP-1 were seen in patients with diabetes type 2.The presence of the greatest number of different forms of IGFBP-1, especiallyoligomeric, in these patients suggests possibly greater involvement of the IGF system inglucose regulation in the state of diabetes. Professional physical training may also leadto alterations in the concentration and structure of IGFBP-1. The total concentration ofIGFBP-1 increases in athletes, however, due to extensive proteolysis, the concentrationof IGFBP-1 fragments increases significantly. The main IGFBP-1 fragment in the seraof athletes is of 9 kDa, and it is most likely produced by the increased activity of matrixmetalloproteinase 9. Altered reactivity of IGFBP-1 in athletes was detected by usingmass spectrometry and chips with different ion-exchange surfaces, suggesting changesin physico-chemical characteristics of IGFBP-1, namely charge density. According toour findings, cigarette smoking, known to cause free radical generation andcardiovascular complications in diabetes, had no effect on oligomerisation (oxidation)of IGFBP-1 in the circulation.In conclusion, changes in glucose metabolism lead to alterations in theconcentration and structure of IGFBP-1. These alterations are mostly expressed thoughmodified oligomerization and proteolysis of IGFBP-1. The formation of complexesbetween IGFBP-1 and α2-macroglobulin seems to resist changes. Since oligomers andfragments of IGFBP-1 mostly do not bind IGF molecules, redistribution of IGFBP-1between several molecular forms, in the case of altered glucose metabolism, can affectdegree of IGF binding or its bioavailability
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze
T1  - Alternation of the structure and reactivity of the insulin-like growth factor binding protein 1 due to glucose metabolism.
UR  - https://hdl.handle.net/21.15107/rcub_nardus_6036
ER  - 
@phdthesis{
author = "Lagundžin, Dragana",
year = "2014",
abstract = "Vezujući proteini za faktore rasta slične insulinu (IGFBP), zajedno sa IGFligandima i IGF receptorima (IGF-1R i IGF-2R) čine sistem koji utiče na rast i razvojskoro svake ćelije, tkiva i organa. IGFBP-1 je jedini od šest IGFBP molekula čija sekoncentracija menja na dnevnoj bazi, u zavisnosti od koncentracije insulina u krvi,odnosno od metaboličkih potreba vezanih za potrošnju glukoze. Kod zdravih osoba jekonstatovano postojanje direktne negativne sprege između koncentracije IGFBP-1 iinsulina, dok se kod osoba sa izmenjenim metabolizmom glukoze ta sprega često gubi.Cilj ovog istraživanja je bio da se ispita da li se i u kojoj meri IGFBP-1 menja posttranslacionoi da li interaguje sa drugim proteinima iz okruženja, što bi moglo doprinetiefektima uočenim na nivou ose IGFBP-1/IGF/insulin kod osoba sa nepravilnimmetabolizmom glukoze ili osoba izloženih metaboličkom opterećenju.Eksperimentalno je utvrđeno postojanje monomera, nekoliko fragmenata,oligomera i kompleksa IGFBP-1. Rezultati su dalje pokazali da se kod osoba saporemećajem u metabolizmu glukoze, kao što su diabetes mellitus ili hipoglikemija,menjaju koncentracije i strukturne karakteristike IGFBP-1. Najintenzivnije posttranslacionepromene IGFBP-1 se javljaju kod pacijenata sa dijabetesom tipa 2.Prisutnost većeg broja različitih molekulskih formi IGFBP-1 kod ovih pacijenata, presvega multimera, ukazuje na potencijalno veće učečće IGF sistema u regulacijikoncentracije glukoze u stanju dijabetesa. Profesionalno bavljenje sportom, takođe,dovodi do promene u koncentraciji i strukturi IGFBP-1. Koncentracija ukupnog IGFBP-1 raste kod sportista ali, usled povećane proteolize, značajno se uvećava udeo IGFBP-1fragmenata. Glavni fragment IGFBP-1 u serumu sportista je mase 9 kDa i, verovatno,nastaje kao posledica povećane aktivnosti matriksne metaloproteaze 9. Primenommasene spektrometrije, kod sportista je ustanovljena izmenjena reaktivnost IGFBP-1 načipovima sa različitim jonoizmenjivačkim površinama, ukazujući na promenu u fizičkohemijskimkarakteristikama IGFBP-1, pre svega u naelektrisanju. Pušenje, kao uzročnikstvaranja slobodnih radikala i dodatni faktor rizika od vaskularnih komplikacija koddijabetičara, prema dobijenim rezultatima, nije od uticaja na oligomerizaciju(oksidaciju) IGFBP-1 u cirkulaciji.Na kraju, opšti zaključak bi bio da promene u metabolizmu glukoze, bez obzirada li su izazvane poremećajima ili povećanom potrebom za glukozom, dovode dopromene u koncentraciji i strukturi IGFBP-1, što se u najvećoj meri iskazuje krozizmenjen stepen oligomerizacije i proteolize IGFBP-1. Proces stvaranja kompleksaIGFBP-1 sa α2-makroglobulinom je najotporniji na uticaje. Pošto oligomeri i fragmentiIGFBP-1 uglavnom ne vezuju IGF ligande, redistribucijom IGFBP-1 između višerazličitih molekulskih formi, u uslovima izmenjenog metabolizma glukoze, može seznatno uticati na stepen vezivanja, odnosno biodostupnosti IGF peptida., The insulin-like growth factor binding proteins (IGFBPs), IGF ligands and IGFreceptors (IGF-1R i IGF-2R) comprise a system involved in growth and development ofalmost evey cell, tissue and organ. Among six IGFBPs, IGFBP-1 is the only one thatexhibits diurnal variation and correlates with the level of insulin in blood.Concentrations of IGFBP-1 and insulin are inversely proportional in healthy people.That correlation could be lost in the case of altered glucose metabolism. The aim of thisstudy was to examine whether and to what extent IGFBP-1 changes post-translationallyand whether IGFBP-1 interacts with other proteins in the surrounding that couldcontribute to the effects detected in the IGFBP-1/IGF/insulin axis in persons withimpaired glucose metobolism or in those with hypermetabolism.The existance of IGFBP-1 monomer, several fragments, oligomers andcomplexes was confirmed experimentally. The results have further shown that IGFBP-1concentration and structure undergo certain changes in patients with impaired glucosemetabolism, as in the case of diabetes mellitus and hypoglicemia. The most pronouncedpost-translational modifications of IGFBP-1 were seen in patients with diabetes type 2.The presence of the greatest number of different forms of IGFBP-1, especiallyoligomeric, in these patients suggests possibly greater involvement of the IGF system inglucose regulation in the state of diabetes. Professional physical training may also leadto alterations in the concentration and structure of IGFBP-1. The total concentration ofIGFBP-1 increases in athletes, however, due to extensive proteolysis, the concentrationof IGFBP-1 fragments increases significantly. The main IGFBP-1 fragment in the seraof athletes is of 9 kDa, and it is most likely produced by the increased activity of matrixmetalloproteinase 9. Altered reactivity of IGFBP-1 in athletes was detected by usingmass spectrometry and chips with different ion-exchange surfaces, suggesting changesin physico-chemical characteristics of IGFBP-1, namely charge density. According toour findings, cigarette smoking, known to cause free radical generation andcardiovascular complications in diabetes, had no effect on oligomerisation (oxidation)of IGFBP-1 in the circulation.In conclusion, changes in glucose metabolism lead to alterations in theconcentration and structure of IGFBP-1. These alterations are mostly expressed thoughmodified oligomerization and proteolysis of IGFBP-1. The formation of complexesbetween IGFBP-1 and α2-macroglobulin seems to resist changes. Since oligomers andfragments of IGFBP-1 mostly do not bind IGF molecules, redistribution of IGFBP-1between several molecular forms, in the case of altered glucose metabolism, can affectdegree of IGF binding or its bioavailability",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze, Alternation of the structure and reactivity of the insulin-like growth factor binding protein 1 due to glucose metabolism.",
url = "https://hdl.handle.net/21.15107/rcub_nardus_6036"
}
Lagundžin, D.. (2014). Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_6036
Lagundžin D. Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze. in Универзитет у Београду. 2014;.
https://hdl.handle.net/21.15107/rcub_nardus_6036 .
Lagundžin, Dragana, "Promena strukture i reaktivnosti vezujućeg proteina 1 za faktore rasta slične insulinu kao posledica metabolizma glukoze" in Универзитет у Београду (2014),
https://hdl.handle.net/21.15107/rcub_nardus_6036 .